{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:13:40Z","timestamp":1788066820882,"version":"build-2784847793"},"reference-count":485,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2020\/004640"],"award-info":[{"award-number":["CRG\/2020\/004640"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007488","name":"Indian Institute of Technology Delhi","doi-asserted-by":"publisher","award":["MI02697G"],"award-info":[{"award-number":["MI02697G"]}],"id":[{"id":"10.13039\/501100007488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021954","name":"Tour de Cure Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bioactmat.2023.11.007","type":"journal-article","created":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T23:24:29Z","timestamp":1701041069000},"page":"396-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Engineered smart materials for RNA based molecular therapy to treat Glioblastoma"],"prefix":"10.1016","volume":"33","author":[{"given":"Ravi Raj","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1497-7317","authenticated-orcid":false,"given":"Indranil","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taskeen","family":"Janjua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5401-3446","authenticated-orcid":false,"given":"Amirali","family":"Popat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Kulshreshtha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2023.11.007_bib1","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A7462","article-title":"The 2021 world health organization classification of tumors of the central nervous system: what neuroradiologists need to know","author":"Osborn","year":"2022","journal-title":"Am. J. Neuroradiol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib2","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1634\/theoncologist.2009-0121","article-title":"FDA drug approval summary: bevacizumab (Avastin\u00ae) as treatment of recurrent glioblastoma multiforme","volume":"14","author":"Cohen","year":"2009","journal-title":"Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12017-021-08689-5","article-title":"Chimeric antigen receptor (CAR) T cell therapy for glioblastoma","volume":"24","author":"Feldman","year":"2022","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.662064","article-title":"CAR T cell-based immunotherapy for the treatment of glioblastoma","volume":"15","author":"Maggs","year":"2021","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41698-021-00233-9","article-title":"GD2 CAR T cells against human glioblastoma","volume":"5","author":"Prapa","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061372","article-title":"Non-coding RNAs in cancer diagnosis and therapy: focus on lung cancer","volume":"13","author":"Le","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-019-0748-z","article-title":"Noncoding RNAs in cancer therapy resistance and targeted drug development","volume":"12","author":"Wang","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"Macfarlane","year":"2010","journal-title":"Curr. Genom."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225573","article-title":"Mechanisms and functions of long non-coding RNAs at multiple regulatory levels","volume":"20","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12964-021-00809-9","article-title":"Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms","volume":"20","author":"Salami","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12964-020-00657-z","article-title":"PIWI-interacting RNAs and PIWI proteins in glioma: molecular pathogenesis and role as biomarkers","volume":"18","author":"Tamtaji","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13046-020-01700-0","article-title":"Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark","volume":"39","author":"Zhao","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib15","series-title":"AGO-driven Non-coding RNAs","first-page":"261","article-title":"Chapter 10 - MicroRNA therapeutics in glioblastoma: candidates and targeting strategies","author":"Mondal","year":"2019"},{"issue":"14","key":"10.1016\/j.bioactmat.2023.11.007_bib16","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib17","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111801","article-title":"Impact of age and gender on glioblastoma onset, progression, and management","volume":"211","author":"Colopi","year":"2023","journal-title":"Mech. Ageing Dev."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib21","series-title":"Epidemiology and Outcome of Glioblastoma","author":"Tamimi","year":"2017"},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib22","first-page":"e8195","article-title":"Rising incidence of glioblastoma multiforme in a well-defined population","volume":"12","author":"Grech","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3857\/roj.2020.00591","article-title":"Clinical behaviour and outcome in pediatric glioblastoma: current scenario","volume":"39","author":"Singla","year":"2021","journal-title":"Radiat. Oncol. J"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-12-3002","article-title":"The definition of primary and secondary glioblastoma","volume":"19","author":"Ohgaki","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib26","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients","volume":"10","author":"Ostermann","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5732\/cjc.013.10207","article-title":"Standards of care and novel approaches in the management of glioblastoma multiforme","volume":"33","author":"Hottinger","year":"2014","journal-title":"Chin. J. Cancer"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11060-016-2171-4","article-title":"Technical principles in glioma surgery and preoperative considerations","volume":"130","author":"Krivosheya","year":"2016","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clineuro.2017.10.008","article-title":"Precision surgery of rolandic glioma and insights from extended functional mapping","volume":"163","author":"Flouty","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.molmed.2018.07.003","article-title":"An experimenter's Guide to glioblastoma invasion pathways","volume":"24","author":"de Gooijer","year":"2018","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/jjco\/hys016","article-title":"The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas","volume":"42","author":"Yamaguchi","year":"2012","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib32","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/brain\/awm204","article-title":"Long-term survival with glioblastoma multiforme","volume":"130","author":"Krex","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib33","series-title":"Current Understanding and Treatment of Gliomas","first-page":"49","article-title":"Radiation therapy of glioblastoma","author":"Barani","year":"2015"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00748","article-title":"Advances in radiotherapy for glioblastoma","volume":"8","author":"Mann","year":"2018","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrc2587","article-title":"Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype","volume":"9","author":"Barnett","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib36","series-title":"Current Standards of Care in Glioblastoma Therapy","first-page":"197","author":"Fernandes","year":"2017"},{"issue":"19","key":"10.1016\/j.bioactmat.2023.11.007_bib37","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1158\/1078-0432.CCR-05-0722","article-title":"Food and drug administration drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme","volume":"11","author":"Cohen","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-015-1724-2","article-title":"Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis","volume":"122","author":"Chowdhary","year":"2015","journal-title":"Journal of neuro-oncology"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","author":"Alifieris","year":"2015","journal-title":"Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib42","first-page":"2585","article-title":"Temozolomide and treatment of malignant glioma","volume":"6","author":"Friedman","year":"2000","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11060-013-1110-x","article-title":"The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience","volume":"113","author":"Gutenberg","year":"2013","journal-title":"J. Neuro Oncol."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neurol.2017.09.011","article-title":"How safe are carmustine wafers?","volume":"174","author":"Grangeon","year":"2018","journal-title":"Rev. Neurol."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/cns.15.8","article-title":"Use of bevacizumab in recurrent glioblastoma","volume":"4","author":"Ghiaseddin","year":"2015","journal-title":"CNS Oncol"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jocn.2020.01.066","article-title":"Impact of adverse events of bevacizumab on survival outcomes of patients with recurrent glioblastoma","volume":"74","author":"Kamiya-Matsuoka","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib47","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.7150\/jca.53198","article-title":"Peri-tumoral brain edema associated with glioblastoma correlates with tumor recurrence","volume":"12","author":"Qin","year":"2021","journal-title":"J. Cancer"},{"issue":"188","key":"10.1016\/j.bioactmat.2023.11.007_bib48","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2021.0922","article-title":"Modelling glioma progression, mass effect and intracranial pressure in patient anatomy","volume":"19","author":"Lipkov\u00e1","year":"2022","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib49","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.semcancer.2019.10.010","article-title":"Brain malignancies: glioblastoma and brain metastases","volume":"60","author":"Lah","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11864-019-0619-4","article-title":"Current state of immunotherapy for treatment of glioblastoma","volume":"20","author":"McGranahan","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00242","article-title":"Immune checkpoint in glioblastoma: promising and challenging","volume":"8","author":"Huang","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib53","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/noy032","article-title":"CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges","volume":"20","author":"Bagley","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00702","article-title":"Effective treatment of glioblastoma multiforme with oncolytic virotherapy: a case-series","volume":"10","author":"Gesundheit","year":"2020","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib55","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41591-018-0142-3","article-title":"Immunotherapy for glioblastoma: going viral","volume":"24","author":"Iorgulescu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114035","article-title":"Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: state of the art and future perspectives","volume":"179","author":"Abadi","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11060-014-1502-6","article-title":"Vaccine therapies for patients with glioblastoma","volume":"119","author":"Sayegh","year":"2014","journal-title":"J. Neuro Oncol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/21645515.2017.1388481","article-title":"Vaccination in the immunotherapy of glioblastoma","volume":"14","author":"Kong","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib59","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3174\/ajnr.A4362","article-title":"Current applications of MRI-guided laser interstitial thermal therapy in the treatment of brain neoplasms and epilepsy: a radiologic and neurosurgical overview","volume":"36","author":"Medvid","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/neuros\/nyy375","article-title":"Glioblastoma treated with magnetic resonance imaging-guided laser interstitial thermal therapy: safety, efficacy, and outcomes","volume":"84","author":"Kamath","year":"2019","journal-title":"Neurosurgery"},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib61","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1080\/02656736.2018.1430867","article-title":"Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans","volume":"34","author":"Mahmoudi","year":"2018","journal-title":"Int. J. Hyperther."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/02656736.2020.1783461","article-title":"The effect of thermal therapy on the blood-brain barrier and blood-tumor barrier","volume":"37","author":"Patel","year":"2020","journal-title":"Int. J. Hyperther. : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib63","doi-asserted-by":"crossref","first-page":"vdaa071","DOI":"10.1093\/noajnl\/vdaa071","article-title":"Therapeutic enhancement of blood\u2013brain and blood\u2013tumor barriers permeability by laser interstitial thermal therapy","volume":"2","author":"Salehi","year":"2020","journal-title":"Neuro-Oncology Advances"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148613","article-title":"Hyperthermic laser ablation of recurrent glioblastoma leads to temporary disruption of the peritumoral blood brain barrier","volume":"11","author":"Leuthardt","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib65","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2016.7.FOCUS16234","article-title":"Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma","volume":"41","author":"Thomas","year":"2016","journal-title":"Neurosurgical Focus FOC"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib66","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3171\/2015.7.JNS15244","article-title":"Intracranial MR-guided laser-induced thermal therapy: single-center experience with the Visualase thermal therapy system","volume":"125","author":"Patel","year":"2016","journal-title":"Journal of Neurosurgery JNS"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11060-018-2768-x","article-title":"Tumor treating fields: a new approach to glioblastoma therapy","volume":"137","author":"Rick","year":"2018","journal-title":"J. Neuro Oncol."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib68","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-020-01136-5","article-title":"Tumour treating fields therapy for glioblastoma: current advances and future directions","volume":"124","author":"Rominiyi","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib69","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.21873\/anticanres.14597","article-title":"Clinical efficacy of tumor treating fields for newly diagnosed glioblastoma","volume":"40","author":"Liu","year":"2020","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib70","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-020-01136-5","article-title":"Tumour treating fields therapy for glioblastoma: current advances and future directions","volume":"124","author":"Rominiyi","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib71","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11060-019-03098-y","article-title":"5-ALA and FDA approval for glioma surgery","volume":"141","author":"Hadjipanayis","year":"2019","journal-title":"J. Neuro Oncol."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib72","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2014.9.FOCUS14516","article-title":"Bevacizumab for glioblastoma: current indications, surgical implications, and future directions","volume":"37","author":"Castro","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib73","series-title":"FDA Grants Accelerated Approval to Dabrafenib in Combination with Trametinib for Unresectable or Metastatic Solid Tumors with BRAF V600E Mutation","year":"2022"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1470-2045(21)00578-7","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600E)-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial","volume":"23","author":"Wen","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib75","series-title":"Beactica Therapeutics Receives FDA Orphan Drug Designation for BEA-17 for the Treatment of Glioblastoma","author":"Beactica Therapeutics","year":"2023"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib76","series-title":"Beactica Therapeutics Receives FDA Orphan Drug Designation for BEA-17 for the Treatment of Glioblastoma","author":"Therapeutics","year":"2023"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib77","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.omtn.2020.07.005","article-title":"Targeting long non-coding RNA to therapeutically regulate gene expression in cancer","volume":"21","author":"Fu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tibs.2018.09.012","article-title":"Revealing lncRNA structures and interactions by sequencing-based approaches","volume":"44","author":"Qian","year":"2019","journal-title":"Trends Biochem. Sci."},{"issue":"7414","key":"10.1016\/j.bioactmat.2023.11.007_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"issue":"7414","key":"10.1016\/j.bioactmat.2023.11.007_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Dunham","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib81","series-title":"Noncoding RNAs in Glioblastoma","first-page":"95","author":"Zhang","year":"2017"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib82","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2017.99","article-title":"Non-coding RNA networks in cancer","volume":"18","author":"Anastasiadou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.bioactmat.2023.11.007_bib83","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.bioactmat.2023.11.007_bib84","doi-asserted-by":"crossref","first-page":"i426","DOI":"10.1093\/bioinformatics\/btq363","article-title":"Classification of ncRNAs using position and size information in deep sequencing data","volume":"26","author":"Erhard","year":"2010","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib85","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-15-127","article-title":"Prediction and classification of ncRNAs using structural information","volume":"15","author":"Panwar","year":"2014","journal-title":"BMC Genom."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib86","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jcp.30577","article-title":"Metastasis associated long noncoding RNAs in glioblastoma: biomarkers and therapeutic targets","volume":"237","author":"Yadav","year":"2022","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13543776.2021.1837775","article-title":"Potential of microRNA based diagnostics and therapeutics in glioma: a patent review","volume":"31","author":"Mondal","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib88","article-title":"Systematic characterization and biological functions of non-coding RNAs in glioblastoma","author":"Dai","year":"2022","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tcm.2017.08.002","article-title":"Biology and clinical relevance of noncoding sno\/scaRNAs","volume":"28","author":"Cao","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/biom10060873","article-title":"Human telomerase RNA: telomerase component or more?","volume":"10","author":"Rubtsova","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib91","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-981-15-1671-9_20","article-title":"Y RNAs: biogenesis, function and implications for the cardiovascular system","volume":"1229","author":"Valkov","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib92","doi-asserted-by":"crossref","first-page":"E1106","DOI":"10.1073\/pnas.1420955112","article-title":"Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs","volume":"112","author":"Londin","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib93","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"MicroRNAs in cancer","volume":"4","author":"Lee","year":"2009","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib94","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12031-018-1204-1","article-title":"The role of MicroRNAs in patients with amyotrophic lateral sclerosis","volume":"66","author":"Dardiotis","year":"2018","journal-title":"J. Mol. Neurosci. : M. Inc."},{"issue":"23","key":"10.1016\/j.bioactmat.2023.11.007_bib95","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.drudis.2009.09.009","article-title":"MicroRNAs: novel therapeutic targets in neurodegenerative diseases","volume":"14","author":"Roshan","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/970607","article-title":"Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation","volume":"2014","author":"Valinezhad Orang","year":"2014","journal-title":"Int J Genomics"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib97","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2353\/ajpath.2009.080794","article-title":"MiRNAs and cancer","volume":"174","author":"Visone","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib99","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1080\/15548627.2019.1569947","article-title":"MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy","volume":"15","author":"Huang","year":"2019","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib100","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/onc.2010.465","article-title":"MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-\u03b28","volume":"30","author":"Fang","year":"2011","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib101","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1096\/fj.11-202820","article-title":"Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma","volume":"26","author":"Smits","year":"2012","journal-title":"Faseb. J."},{"issue":"No 6","key":"10.1016\/j.bioactmat.2023.11.007_bib102","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3009","article-title":"MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15\/16 activity in glioblastoma","volume":"6","author":"Teplyuk","year":"2015","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.bioactmat.2023.11.007_bib103","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","article-title":"MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells","volume":"68","author":"Papagiannakopoulos","year":"2008","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib104","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4161\/cbt.24597","article-title":"microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells","volume":"14","author":"Comincini","year":"2013","journal-title":"Cancer Biol. Ther."},{"issue":"21","key":"10.1016\/j.bioactmat.2023.11.007_bib105","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/onc.2010.620","article-title":"Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas","volume":"30","author":"Kwak","year":"2011","journal-title":"Oncogene"},{"issue":"26","key":"10.1016\/j.bioactmat.2023.11.007_bib106","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1038\/onc.2011.15","article-title":"MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4","volume":"30","author":"Schramedei","year":"2011","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.bioactmat.2023.11.007_bib107","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1128\/MCB.00479-08","article-title":"MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators","volume":"28","author":"Gabriely","year":"2008","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib108","first-page":"1819","article-title":"miR-7-5p inhibits cell migration and invasion in glioblastoma through targeting SATB1","volume":"17","author":"Yin","year":"2019","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib109","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3892\/ijo.2014.2322","article-title":"miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K\/ATK and Raf\/MEK\/ERK pathways","volume":"44","author":"Liu","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib110","doi-asserted-by":"crossref","first-page":"10177","DOI":"10.1007\/s13277-014-2318-x","article-title":"MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1","volume":"35","author":"Liu","year":"2014","journal-title":"Tumor Biol."},{"issue":"19","key":"10.1016\/j.bioactmat.2023.11.007_bib111","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1158\/0008-5472.CAN-09-0529","article-title":"MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib112","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/onc.2012.132","article-title":"miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme","volume":"32","author":"Yin","year":"2013","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib113","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.arcmed.2010.02.007","article-title":"MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251","volume":"41","author":"Luan","year":"2010","journal-title":"Arch. Med. Res."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib114","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4161\/cc.9.6.10987","article-title":"microRNA-34a is tumor suppressive in brain tumors and glioma stem cells","volume":"9","author":"Guessous","year":"2010","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4161\/cbt.12.6.16300","article-title":"MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme","volume":"12","author":"Li","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib116","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3892\/mmr.2016.5255","article-title":"MicroRNA-34a inhibits cell proliferation and induces cell apoptosis of glioma cells via targeting of Bcl-2","volume":"14","author":"Duan","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib117","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.fob.2014.05.002","article-title":"Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways","volume":"4","author":"Rathod","year":"2014","journal-title":"FEBS Open Bio"},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108514","article-title":"Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033844","article-title":"miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis","volume":"7","author":"Silber","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib120","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4161\/rna.8.5.16041","article-title":"The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs","volume":"8","author":"Vo","year":"2011","journal-title":"RNA Biol."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib121","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-009-0077-0","article-title":"Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation","volume":"98","author":"Cui","year":"2010","journal-title":"J. Neuro Oncol."},{"issue":"15","key":"10.1016\/j.bioactmat.2023.11.007_bib122","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/onc.2011.380","article-title":"Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases","volume":"31","author":"Papagiannakopoulos","year":"2012","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib123","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/neuonc\/not055","article-title":"MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells","volume":"15","author":"Peruzzi","year":"2013","journal-title":"Neuro Oncol."},{"issue":"22","key":"10.1016\/j.bioactmat.2023.11.007_bib124","doi-asserted-by":"crossref","first-page":"9125","DOI":"10.1158\/0008-5472.CAN-08-2629","article-title":"Targeting of the bmi-1 oncogene\/stem cell renewal factor by MicroRNA-128 inhibits glioma proliferation and self-renewal","volume":"68","author":"Godlewski","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib125","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41467-019-08390-z","article-title":"The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma","volume":"10","author":"Bhaskaran","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032709","article-title":"MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1","volume":"7","author":"Shi","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib127","first-page":"4577","article-title":"MicroRNA-10b-5p downregulation inhibits the invasion of glioma cells via modulating homeobox B3 expression","volume":"17","author":"Li","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib128","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1007\/s13277-015-3310-9","article-title":"Correlation of microRNA-10b upregulation and poor prognosis in human gliomas","volume":"36","author":"Ji","year":"2015","journal-title":"Tumor Biol."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib129","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/ijc.24522","article-title":"MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC","volume":"125","author":"Sasayama","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib130","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.134","article-title":"MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme","volume":"3","author":"Lin","year":"2012","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11060-013-1047-0","article-title":"Oncogenic effects of miR-10b in glioblastoma stem cells","volume":"112","author":"Guessous","year":"2013","journal-title":"J. Neuro Oncol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib132","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1158\/0008-5472.CAN-10-3568","article-title":"Human glioma growth is controlled by MicroRNA-10b","volume":"71","author":"Gabriely","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib133","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/jcb.26300","article-title":"MiR-21: a key player in glioblastoma pathogenesis","volume":"119","author":"Masoudi","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib134","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.toxrep.2020.11.001","article-title":"The role of MiRNA-21 in gliomas: hope for a novel therapeutic intervention?","volume":"7","author":"Aloizou","year":"2020","journal-title":"Toxicol Rep"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib135","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1242\/bio.015552","article-title":"MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide","volume":"5","author":"Chen","year":"2016","journal-title":"Biology open"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib136","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainres.2010.07.009","article-title":"MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax\/Bcl-2 ratio and caspase-3 activity","volume":"1352","author":"Shi","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib137","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2015.04.002","article-title":"MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: a new multimodal gene therapy approach for glioblastoma","volume":"207","author":"Costa","year":"2015","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib138","first-page":"2835","article-title":"MicroRNA-21 inhibition enhances <em>In vitro<\/em> chemosensitivity of temozolomide-resistant glioblastoma cells","volume":"32","author":"Wong","year":"2012","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib139","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3892\/ijo.2015.2841","article-title":"Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes","volume":"46","author":"Zhang","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-10-27","article-title":"MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol","volume":"10","author":"Ren","year":"2010","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib141","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/neuonc\/nor033","article-title":"Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo","volume":"13","author":"Gaur","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib142","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2009.06.053","article-title":"MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme","volume":"1286","author":"Li","year":"2009","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib143","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/cancers6020625","article-title":"MicroRNAs in the regulation of MMPs and metastasis","volume":"6","author":"Abba","year":"2014","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.bioactmat.2023.11.007_bib144","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1128\/MCB.00479-08","article-title":"MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators","volume":"28","author":"Gabriely","year":"2008","journal-title":"Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib145","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.3892\/ol.2017.6052","article-title":"Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN\/PDCD4","volume":"13","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib146","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3892\/mmr.2013.1814","article-title":"MicroRNA-203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2","volume":"9","author":"Chen","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"15","key":"10.1016\/j.bioactmat.2023.11.007_bib147","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1158\/0008-5472.CAN-10-4645","article-title":"MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma","volume":"71","author":"Ibrahim","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34 \u2013 a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2015.00340","article-title":"Transfection of microRNA mimics should Be used with caution","volume":"6","author":"Jin","year":"2015","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNA"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib151","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/1061186X.2014.1000336","article-title":"Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy","volume":"23","author":"Song","year":"2015","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib152","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/1061186X.2016.1207648","article-title":"Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model","volume":"25","author":"Oh","year":"2017","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib153","first-page":"195","article-title":"Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3","volume":"24","author":"Zhou","year":"2010","journal-title":"Oncol. Rep."},{"issue":"18","key":"10.1016\/j.bioactmat.2023.11.007_bib154","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting MicroRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/AAC.04220-14","article-title":"In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122","volume":"59","author":"Ottosen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib156","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/labinvest.2009.126","article-title":"Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status","volume":"90","author":"Zhou","year":"2010","journal-title":"Lab. Invest."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib157","article-title":"Improved Performance of anti-miRNA oligonucleotides Using a novel non-nucleotide modifier. Molecular therapy","volume":"2","author":"Lennox","year":"2013","journal-title":"Nucleic acids"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib158","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/clpt.2012.192","article-title":"Clinical applications for microRNAs in cancer","volume":"93","author":"Nana-Sinkam","year":"2013","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib159","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2052-8426-1-5","article-title":"Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma","volume":"1","author":"Shibata","year":"2013","journal-title":"Molecular and Cellular Therapies"},{"issue":"23","key":"10.1016\/j.bioactmat.2023.11.007_bib160","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1158\/1078-0432.CCR-17-3024","article-title":"Therapeutic targeting of TGF\u03b2 ligands in glioblastoma using novel antisense oligonucleotides reduces the growth of experimental gliomas","volume":"25","author":"Papachristodoulou","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib161","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.omtn.2021.12.029","article-title":"Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells","volume":"27","author":"Adamus","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib162","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2019.11.009","article-title":"Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes","volume":"317","author":"Kim","year":"2020","journal-title":"J. Contr. Release"},{"issue":"35","key":"10.1016\/j.bioactmat.2023.11.007_bib163","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1039\/D1NR03455C","article-title":"Intranasal delivery of self-assembled nanoparticles of therapeutic peptides and antagomirs elicits anti-tumor effects in an intracranial glioblastoma model","volume":"13","author":"Ha","year":"2021","journal-title":"Nanoscale"},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib164","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103812","article-title":"Anti-MicroRNA-21 oligonucleotide loaded spermine-modified acetalated dextran nanoparticles for B1 receptor-targeted gene therapy and antiangiogenesis therapy","volume":"9","author":"Zheng","year":"2022","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib165","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3892\/or.2014.3012","article-title":"A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo","volume":"31","author":"Chen","year":"2014","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib166","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1261\/rna.2414110","article-title":"MicroRNA sponges: progress and possibilities","volume":"16","author":"Ebert","year":"2010","journal-title":"RNA"},{"issue":"39","key":"10.1016\/j.bioactmat.2023.11.007_bib167","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1002\/anie.200801555","article-title":"Small-molecule inhibitors of MicroRNA miR-21 function","volume":"47","author":"Gumireddy","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib168","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/anie.201106455","article-title":"The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor","volume":"51","author":"Bose","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib169","article-title":"Long non-coding RNAs and nuclear factor-\u03baB crosstalk in cancer and other human diseases","volume":"1873","author":"Gupta","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4161\/bioa.22592","article-title":"Sizing up long non-coding RNAs: do lncRNAs have secondary and tertiary structure?","volume":"2","author":"Novikova","year":"2012","journal-title":"BioArchitecture"},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib171","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/bib\/bby055","article-title":"The small peptide world in long noncoding RNAs","volume":"20","author":"Choi","year":"2019","journal-title":"Briefings Bioinf."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib172","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib173","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1158\/1535-7163.MCT-16-0320","article-title":"The potential roles of long noncoding RNAs (lncRNA) in glioblastoma development","volume":"15","author":"Liu","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib174","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/mt.2015.170","article-title":"Gas5 exerts tumor-suppressive functions in human glioma cells by targeting miR-222","volume":"23","author":"Zhao","year":"2015","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib175","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jcp.26889","article-title":"Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p","volume":"234","author":"Liu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib176","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2147\/NDT.S137171","article-title":"Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt\/& beta;-catenin signaling pathway","volume":"13","author":"Wang","year":"2017","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"107","key":"10.1016\/j.bioactmat.2023.11.007_bib177","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000568","article-title":"Noncoding RNA Gas5 is a growth arrest\u2013 and starvation-associated repressor of the glucocorticoid receptor","volume":"3","author":"Kino","year":"2010","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib178","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1002\/jcb.27900","article-title":"Long noncoding RNA growth arrest-specific 5 facilitates glioma cell sensitivity to cisplatin by suppressing excessive autophagy in an mTOR-dependent manner","volume":"120","author":"Huo","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib179","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cellsig.2014.11.011","article-title":"Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21","volume":"27","author":"Wang","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib180","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.omtn.2019.09.005","article-title":"Blocking lncRNA MALAT1\/miR-199a\/ZHX1 Axis inhibits glioblastoma proliferation and progression","volume":"18","author":"Liao","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib181","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/1078-0432.CCR-17-0605","article-title":"Long noncoding RNA NEAT1, regulated by the EGFR pathway, contributes to glioblastoma progression through the WNT\/\u03b2-Catenin pathway by scaffolding EZH2","volume":"24","author":"Chen","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"No 10","key":"10.1016\/j.bioactmat.2023.11.007_bib182","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3229","article-title":"HOTAIR is a therapeutic target in glioblastoma","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib183","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3727\/096504017X14886689179993","article-title":"Long noncoding RNA MEG3 suppresses glioma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of miR-19a","volume":"25","author":"Qin","year":"2017","journal-title":"Oncology research"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib184","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3171\/2014.12.JNS1426","article-title":"Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells","volume":"124","author":"Jiang","year":"2016","journal-title":"Journal of Neurosurgery JNS"},{"issue":"19","key":"10.1016\/j.bioactmat.2023.11.007_bib185","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.7150\/jca.21024","article-title":"Long non-coding RNA XIST promotes glioma tumorigenicity and angiogenesis by acting as a molecular sponge of miR-429","volume":"8","author":"Cheng","year":"2017","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib186","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.molcel.2010.08.011","article-title":"The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation","volume":"39","author":"Tripathi","year":"2010","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib187","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3346\/jkms.2016.31.5.688","article-title":"Silencing of long non-coding RNA MALAT1 promotes apoptosis of glioma cells","volume":"31","author":"Xiang","year":"2016","journal-title":"J. Kor. Med. Sci."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib188","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1111\/jcmm.13667","article-title":"LncRNA MALAT1\/miR-129 axis promotes glioma tumorigenesis by targeting SOX2","volume":"22","author":"Xiong","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib189","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11060-017-2498-5","article-title":"Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101","volume":"134","author":"Li","year":"2017","journal-title":"J. Neuro Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-018-0849-2","article-title":"Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132","volume":"17","author":"Zhou","year":"2018","journal-title":"Mol. Cancer"},{"issue":"No 38","key":"10.1016\/j.bioactmat.2023.11.007_bib191","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11403","article-title":"Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e","volume":"7","author":"Gong","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib192","first-page":"1","article-title":"HOTAIR: an oncogenic long non-coding RNA in different cancers","volume":"12","author":"Hajjari","year":"2015","journal-title":"Cancer biology & medicine"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib193","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12943-018-0822-0","article-title":"Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme","volume":"17","author":"Tan","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib194","article-title":"Hypoxia induces H19 expression through direct and indirect Hif-1\u03b1 activity, promoting oncogenic effects in glioblastoma","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000494002","article-title":"H19 functions as a competing endogenous RNA to regulate EMT by sponging miR-130a-3p in glioma","volume":"50","author":"Hu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"21","key":"10.1016\/j.bioactmat.2023.11.007_bib196","doi-asserted-by":"crossref","first-page":"15512","DOI":"10.18632\/oncotarget.24496","article-title":"The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter","volume":"9","author":"Fazi","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib197","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib198","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ymthe.2017.03.023","article-title":"FDA-approved oligonucleotide therapies in 2017","volume":"25","author":"Stein","year":"2017","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib199","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-scale CRISPR-mediated control of gene repression and activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib200","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nmeth.3630","article-title":"Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements","volume":"12","author":"Thakore","year":"2015","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib201","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb2608s83","article-title":"Using morpholinos to control gene expression","volume":"83","author":"Moulton","year":"2008","journal-title":"Curr. Protoc. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib202","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/nar\/gkx1221","article-title":"Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide","volume":"46","author":"Kim","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib203","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13616","article-title":"Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment","volume":"7","author":"Katsushima","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib204","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0092-8674(93)90279-Y","article-title":"Circular transcripts of the testis-determining gene Sry in adult mouse testis","volume":"73","author":"Capel","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib205","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164185","article-title":"Mechanisms regulating abnormal circular RNA biogenesis in cancer","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib206","doi-asserted-by":"crossref","first-page":"e1528","DOI":"10.1002\/wrna.1528","article-title":"Computational approaches for circular RNA analysis","volume":"10","author":"Jakobi","year":"2019","journal-title":"WIREs RNA"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib207","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.bbrc.2019.02.019","article-title":"CircRNA hsa-circ-0014359 promotes glioma progression by regulating miR-153\/PI3K signaling","volume":"510","author":"Shi","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12943-019-1120-1","article-title":"Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas","volume":"19","author":"He","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib209","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13046-019-1065-7","article-title":"FUS\/circ_002136\/miR-138-5p\/SOX13 feedback loop regulates angiogenesis in Glioma","volume":"38","author":"He","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib210","doi-asserted-by":"crossref","first-page":"13737","DOI":"10.1002\/jcb.28646","article-title":"Upregulation of circular RNA circ_0034642 indicates unfavorable prognosis in glioma and facilitates cell proliferation and invasion via the miR-1205\/BATF3 axis","volume":"120","author":"Yi","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib211","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1002\/jcb.27966","article-title":"Circular RNA hsa_circ_0076248 promotes oncogenesis of glioma by sponging miR-181a to modulate SIRT1 expression","volume":"120","author":"Lei","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib212","first-page":"1893","article-title":"Expression profiles and potential functions of circular RNAs in extracellular vesicles isolated from radioresistant glioma cells","volume":"41","author":"Zhao","year":"2019","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib213","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.tranon.2016.12.006","article-title":"Differential expression of circular RNAs in glioblastoma multiforme and its correlation with prognosis","volume":"10","author":"Zhu","year":"2017","journal-title":"Translational Oncology"},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib214","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41419-019-1863-z","article-title":"Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib215","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1111\/jcmm.14541","article-title":"circCPA4 acts as a prognostic factor and regulates the proliferation and metastasis of glioma","volume":"23","author":"Peng","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib216","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jcb.29315","article-title":"Overexpression of circular RNA circ-CDC45 facilitates glioma cell progression by sponging miR-516b and miR-527 and predicts an adverse prognosis","volume":"121","author":"Liu","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib217","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.omtn.2019.06.022","article-title":"Circular RNA circSCAF11 accelerates the glioma tumorigenesis through the miR-421\/SP1\/VEGFA Axis","volume":"17","author":"Meng","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib218","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00398","article-title":"CircPCMTD1 acts as the sponge of miR-224-5p to promote glioma progression","volume":"9","author":"Zheng","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib219","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.gene.2018.11.073","article-title":"Circular RNA HIPK3 promotes glioma progression by binding to miR-124-3p","volume":"690","author":"Hu","year":"2019","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib220","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bbrc.2018.07.081","article-title":"CircRNA circHIPK3 serves as a prognostic marker to promote glioma progression by regulating miR-654\/IGF2BP3 signaling","volume":"503","author":"Jin","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib221","first-page":"5704","article-title":"Circular RNA complement factor H (CFH) promotes glioma progression by sponging miR-149 and regulating AKT1","volume":"24","author":"Bian","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib222","first-page":"2585","article-title":"Circular RNA TTBK2 regulates cell proliferation, invasion and ferroptosis via miR-761\/ITGB8 axis in glioma","volume":"24","author":"Zhang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib223","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020194","article-title":"CircSMARCA5 regulates VEGFA mRNA splicing and angiogenesis in glioblastoma multiforme through the binding of SRSF1","volume":"11","author":"Barbagallo","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib224","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jnci\/djx166","article-title":"Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis","volume":"110","author":"Yang","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"13","key":"10.1016\/j.bioactmat.2023.11.007_bib225","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41388-017-0019-9","article-title":"A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib226","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1038\/s41467-018-06862-2","article-title":"A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198205","article-title":"The role of circular RNAs in viral infection and related diseases","volume":"291","author":"Xie","year":"2021","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib228","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41419-021-03743-3","article-title":"CircRNAs: role in human diseases and potential use as biomarkers","volume":"12","author":"Verduci","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib229","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbrc.2019.01.140","article-title":"Upregulated circular RNA circ_0074027 promotes glioblastoma cell growth and invasion by regulating miR-518a-5p\/IL17RD signaling pathway","volume":"510","author":"Qian","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gene.2018.07.037","article-title":"Decreased circular RNA hsa_circ_0001649 predicts unfavorable prognosis in glioma and exerts oncogenic properties in vitro and in vivo","volume":"676","author":"Wang","year":"2018","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib231","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.bbrc.2018.12.052","article-title":"Circular RNA circ_0034642 elevates BATF3 expression and promotes cell proliferation and invasion through miR-1205 in glioma","volume":"508","author":"Yang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib232","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1089\/dna.2018.4311","article-title":"Circular RNA hsa_circ_0074362 promotes glioma cell proliferation, migration, and invasion by attenuating the inhibition of miR-1236-3p on HOXB7 expression","volume":"37","author":"Duan","year":"2018","journal-title":"DNA Cell Biol."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib233","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s10637-019-00884-3","article-title":"Microarray expression profiles and bioinformatics analysis of mRNAs, lncRNAs, and circRNAs in the secondary temozolomide-resistant glioblastoma","volume":"38","author":"Zhao","year":"2020","journal-title":"Invest. N. Drugs"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib234","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/neuonc\/noaa214","article-title":"EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS\/MEK1\/ERK1-2 signaling","volume":"23","author":"Wei","year":"2021","journal-title":"Neuro Oncol."},{"issue":"5785","key":"10.1016\/j.bioactmat.2023.11.007_bib235","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1126\/science.1129333","article-title":"A distinct small RNA pathway silences selfish genetic elements in the germline","volume":"313","author":"Vagin","year":"2006","journal-title":"Science"},{"issue":"7099","key":"10.1016\/j.bioactmat.2023.11.007_bib236","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nature04917","article-title":"A germline-specific class of small RNAs binds mammalian Piwi proteins","volume":"442","author":"Girard","year":"2006","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.bioactmat.2023.11.007_bib237","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0960-9822(01)00299-8","article-title":"Double-stranded RNA-mediated silencing of genomic tandem repeats and transposable elements in the D. melanogaster germline","volume":"11","author":"Aravin","year":"2001","journal-title":"Curr. Biol."},{"issue":"7217","key":"10.1016\/j.bioactmat.2023.11.007_bib238","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nature07415","article-title":"Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals","volume":"455","author":"Grimson","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib239","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41576-018-0073-3","article-title":"PIWI-interacting RNAs: small RNAs with big functions","volume":"20","author":"Ozata","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib240","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jhep.2013.01.032","article-title":"Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma","volume":"58","author":"Law","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib241","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biomaterials.2016.05.052","article-title":"Multiplex bioimaging of piRNA molecular pathway-regulated theragnostic effects in a single breast cancer cell using a piRNA molecular beacon","volume":"101","author":"Lee","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109780","article-title":"piR-001773 and piR-017184 promote prostate cancer progression by interacting with PCDH9","volume":"76","author":"Zhang","year":"2020","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib243","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/leu.2014.135","article-title":"piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma","volume":"29","author":"Yan","year":"2015","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib244","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.7150\/thno.21740","article-title":"PIWIL3\/OIP5-AS1\/miR-367-3p\/CEBPA feedback loop regulates the biological behavior of glioma cells","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"issue":"No 102","key":"10.1016\/j.bioactmat.2023.11.007_bib245","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.26331","article-title":"piRNA-8041 is downregulated in human glioblastoma and suppresses tumor growth in vitro and in vivo","volume":"9","author":"Jacobs","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib246","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.omtn.2017.12.020","article-title":"PIWIL1\/piRNA-DQ593109 regulates the permeability of the blood-tumor barrier via the MEG3\/miR-330-5p\/RUNX3 Axis","volume":"10","author":"Shen","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib247","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13046-018-0886-0","article-title":"Mechanism of piR-DQ590027\/MIR17HG regulating the permeability of glioma conditioned normal BBB","volume":"37","author":"Leng","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"R1","key":"10.1016\/j.bioactmat.2023.11.007_bib248","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1093\/hmg\/ddu207","article-title":"Natural antisense transcripts","volume":"23","author":"Khorkova","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib249","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nbt.2158","article-title":"Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation","volume":"30","author":"Modarresi","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib250","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.24791","article-title":"Gene therapies for cancer: strategies, challenges and successes","volume":"230","author":"Das","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib251","doi-asserted-by":"crossref","first-page":"e1461","DOI":"10.1002\/wrna.1461","article-title":"Natural antisense transcripts in diseases: from modes of action to targeted therapies","volume":"9","author":"Wanowska","year":"2018","journal-title":"WIREs RNA"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib252","article-title":"Challenges of CRISPR\/Cas9 applications for long non-coding RNA genes","volume":"45","author":"Goyal","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib253","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41587-022-01649-9","article-title":"Precise transcript targeting by CRISPR-Csm complexes","volume":"41","author":"Colognori","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib254","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/hmg\/dds496","article-title":"MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma","volume":"22","author":"Costa","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"42","key":"10.1016\/j.bioactmat.2023.11.007_bib255","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1002\/smll.201500540","article-title":"Combined delivery of temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cells","volume":"11","author":"Bertucci","year":"2015","journal-title":"Small"},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib256","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1021\/acs.molpharmaceut.5b00694","article-title":"Nanoparticle-delivered antisense MicroRNA-21 enhances the effects of temozolomide on glioblastoma cells","volume":"12","author":"Ananta","year":"2015","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib257","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.biomaterials.2013.11.039","article-title":"Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma","volume":"35","author":"Qian","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib258","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1163\/156856209X415828","article-title":"Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro","volume":"21","author":"Ren","year":"2010","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"24","key":"10.1016\/j.bioactmat.2023.11.007_bib259","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1016\/j.biomaterials.2014.04.057","article-title":"Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging","volume":"35","author":"Yang","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib260","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.gendis.2019.09.002","article-title":"Identification of miRNA signature associated with BMP2 and chemosensitivity of TMZ in glioblastoma stem-like cells","volume":"7","author":"Guo","year":"2019","journal-title":"Genes & diseases"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib261","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41598-020-65331-3","article-title":"MicroRNA-128-3p enhances the chemosensitivity of temozolomide in glioblastoma by targeting c-met and EMT","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib262","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lfs.2019.04.023","article-title":"miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt\/\u03b2-catenin signaling via targeting SOX2","volume":"226","author":"Luo","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib263","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104390","article-title":"miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme","volume":"147","author":"Ho","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib264","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.biopha.2015.01.026","article-title":"miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression","volume":"71","author":"Wei","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib265","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/jnc.13174","article-title":"Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt\/\u03b2-catenin signaling in glioblastoma","volume":"134","author":"Lan","year":"2015","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib266","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41467-019-10025-2","article-title":"Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib267","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041299","article-title":"Treatment of human glioblastoma U251 cells with sulforaphane and a peptide nucleic acid (PNA) targeting miR-15b-5p: synergistic effects on induction of apoptosis","volume":"27","author":"Gasparello","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib268","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5241","article-title":"Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti-tubulin tetrahydrothieno[2,3-c]pyridine derivative and a peptide nucleic acid targeting miR-221-3p","volume":"59","author":"Zurlo","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib269","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115991","article-title":"Synergistic effects of A combined treatment of glioblastoma U251 cells with an anti-miR-10b-5p molecule and an AntiCancer agent based on 1-(3\u2032,4\u2032,5\u2032-trimethoxyphenyl)-2-aryl-1H-imidazole scaffold","volume":"23","author":"Zurlo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib270","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22848","article-title":"LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt\/\u03b2-catenin signaling","volume":"35","author":"Lu","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib271","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13046-019-1371-0","article-title":"Modulating lncRNA SNHG15\/CDK6\/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.bioactmat.2023.11.007_bib272","article-title":"Genome-wide CRISPR-cas9 screening identifies NF-\u03baB\/E2F6 responsible for EGFRvIII-associated temozolomide resistance in glioblastoma","volume":"6","author":"Huang","year":"2019","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib273","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-020-01253-y","article-title":"Circular RNA CDR1as disrupts the p53\/MDM2 complex to inhibit Gliomagenesis","volume":"19","author":"Lou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib274","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s10020-021-00293-4","article-title":"Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma","volume":"27","author":"Khan","year":"2021","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib275","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-02153-x","article-title":"Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib276","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3892\/ijo.2015.3308","article-title":"High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222","volume":"48","author":"Brognara","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib277","first-page":"59","article-title":"Targeting miR-155-5p and miR-221-3p by peptide nucleic acids induces caspase-3 activation and apoptosis in temozolomide-resistant T98G glioma cells","volume":"55","author":"Milani","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib278","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2020.12098","article-title":"miR-181a-5p inhibits the proliferation and invasion of drug-resistant glioblastoma cells by targeting F-box protein 11 expression","volume":"20","author":"Wen","year":"2020","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib279","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1021\/acs.accounts.9b00101","article-title":"Theranostic nanoparticles for RNA-based cancer treatment","volume":"52","author":"Revia","year":"2019","journal-title":"Accounts Chem. Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118789","article-title":"Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment","volume":"572","author":"Jana","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"No 36","key":"10.1016\/j.bioactmat.2023.11.007_bib282","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.5926","article-title":"miRNA interventions serve as \u2018magic bullets\u2019 in the reversal of glioblastoma hallmarks","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib283","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41571-021-00529-6","article-title":"The blood\u2013tumour barrier in cancer biology and therapy","volume":"18","author":"Steeg","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"37","key":"10.1016\/j.bioactmat.2023.11.007_bib284","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1039\/C7TB01385J","article-title":"Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting","volume":"5","author":"Bouchoucha","year":"2017","journal-title":"J. Mater. Chem. B"},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib285","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1021\/acsabm.1c00430","article-title":"Ultrasonic atomizer-driven development of biocompatible and biodegradable poly(d,l-lactide-co-glycolide) nanocarrier-encapsulated suberoylanilide hydroxamic acid to combat brain cancer","volume":"4","author":"Kaur","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib286","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib287","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood\u2013brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib288","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib289","first-page":"1181","article-title":"Blood-brain barrier-associated efflux transporters: a significant but underappreciated obstacle to drug development in glioblastoma","volume":"17","author":"Mason","year":"2015","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib290","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pmed.0050008","article-title":"Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma","volume":"5","author":"Cloughesy","year":"2008","journal-title":"PLoS Med."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib291","first-page":"1210","article-title":"Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K\/mTOR inhibitor in a mouse model of glioblastoma","volume":"17","author":"Becker","year":"2015","journal-title":"Neuro Oncol."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib292","first-page":"1210","article-title":"Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K\/mTOR inhibitor in a mouse model of glioblastoma","volume":"17","author":"Becker","year":"2015","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib293","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/acsnano.8b03785","article-title":"Inducing a transient increase in blood\u2013brain barrier permeability for improved liposomal drug therapy of glioblastoma multiforme","volume":"13","author":"Lundy","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib294","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"Supplement_5","key":"10.1016\/j.bioactmat.2023.11.007_bib296","doi-asserted-by":"crossref","first-page":"v133","DOI":"10.1093\/noajnl\/vdab123","article-title":"Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases","volume":"3","author":"Blethen","year":"2021","journal-title":"Neuro-Oncology Advances"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib297","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1139\/cjpp-2018-0401","article-title":"Effects of silica nanoparticles on endolysosome function in primary cultured neurons (1)","volume":"97","author":"Ye","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib298","doi-asserted-by":"crossref","first-page":"e1177","DOI":"10.1002\/cnr2.1177","article-title":"Role of endolysosomes and pH in the pathogenesis and treatment of glioblastoma","volume":"2","author":"Halcrow","year":"2019","journal-title":"Cancer Reports"},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib299","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"20","key":"10.1016\/j.bioactmat.2023.11.007_bib300","article-title":"Extracellular proton concentrations impacts LN229 glioblastoma tumor cell fate via differential modulation of surface lipids","volume":"7","author":"John","year":"2017","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib301","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/neuonc\/now258","article-title":"Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells","volume":"19","author":"Colwell","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib302","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52176","article-title":"Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies","volume":"9","author":"Pombo Antunes","year":"2020","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib303","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7150\/thno.41692","article-title":"Glioma stem cells and their roles within the hypoxic tumor microenvironment","volume":"11","author":"Boyd","year":"2021","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib304","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1139\/cjpp-2018-0401","article-title":"Effects of silica nanoparticles on endolysosome function in primary cultured neurons (1)","volume":"97","author":"Ye","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib305","article-title":"Role of endolysosomes and pH in the pathogenesis and treatment of glioblastoma","volume":"2","author":"Halcrow","year":"2019","journal-title":"Cancer Rep"},{"issue":"12_Part_1","key":"10.1016\/j.bioactmat.2023.11.007_bib306","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs1","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib307","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","article-title":"Angiogenesis in brain tumours","volume":"8","author":"Jain","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib308","article-title":"Pathological and molecular features of glioblastoma and its peritumoral tissue","volume":"11","author":"D'Alessio","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib309","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nnano.2012.45","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","volume":"7","author":"Chauhan","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"51","key":"10.1016\/j.bioactmat.2023.11.007_bib310","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803717","article-title":"Effective and targeted human orthotopic glioblastoma xenograft therapy via a multifunctional biomimetic nanomedicine","volume":"30","author":"Zou","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib311","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.2147\/IJN.S136401","article-title":"Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts","volume":"12","author":"Shen","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"Pt A","key":"10.1016\/j.bioactmat.2023.11.007_bib312","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2015.09.057","article-title":"Self-assembled 20-nm (64)Cu-micelles enhance accumulation in rat glioblastoma","volume":"220","author":"Seo","year":"2015","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib313","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/1535-7163.MCT-16-0616","article-title":"Insulin-mediated signaling facilitates resistance to PDGFR inhibition in proneural hPDGFB-driven gliomas","volume":"16","author":"Almiron Bonnin","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"issue":"43","key":"10.1016\/j.bioactmat.2023.11.007_bib314","doi-asserted-by":"crossref","first-page":"74451","DOI":"10.18632\/oncotarget.20165","article-title":"Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"issue":"40","key":"10.1016\/j.bioactmat.2023.11.007_bib315","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1039\/D1NR03553C","article-title":"Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma","volume":"13","author":"Janjua","year":"2021","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib316","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611861003734001","article-title":"Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB)","volume":"19","author":"Ulbrich","year":"2011","journal-title":"J. Drug Target."},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib317","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1021\/acs.molpharmaceut.7b00569","article-title":"Large amino acid transporter 1 selective liposomes of l-DOPA functionalized amphiphile for combating glioblastoma","volume":"14","author":"Bhunia","year":"2017","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib318","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/1061186X.2015.1077849","article-title":"Preparation, characterization and in vitro-targeted delivery of novel Apolipoprotein E-based nanoparticles to C6 glioma with controlled size and loading efficiency","volume":"24","author":"Maleklou","year":"2016","journal-title":"J. Drug Target."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib319","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1021\/acsnano.7b06969","article-title":"Ferritin nanocarrier traverses the blood brain barrier and kills glioma","volume":"12","author":"Fan","year":"2018","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib320","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1021\/acsnano.1c07492","article-title":"Systemic delivery of an adjuvant CXCR4\u2013CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy","volume":"16","author":"Alghamri","year":"2022","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.bioactmat.2023.11.007_bib321","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2174\/1568026615666150330110822","article-title":"Chlorotoxin-conjugated nanoparticles for targeted imaging and therapy of glioma","volume":"15","author":"Zhao","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib322","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1080\/10717544.2018.1494223","article-title":"Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles","volume":"25","author":"Liang","year":"2018","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib323","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.biomaterials.2012.10.048","article-title":"F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery","volume":"34","author":"Hu","year":"2013","journal-title":"Biomaterials"},{"issue":"24","key":"10.1016\/j.bioactmat.2023.11.007_bib324","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1021\/jacs.5b03991","article-title":"A new interleukin-13 amino-coated gadolinium metallofullerene nanoparticle for targeted MRI detection of glioblastoma tumor cells","volume":"137","author":"Li","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib325","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.20048","article-title":"Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles","volume":"109","author":"Steiniger","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"23","key":"10.1016\/j.bioactmat.2023.11.007_bib326","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2217\/nnm-2016-0240","article-title":"Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles","volume":"11","author":"Kong","year":"2016","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib327","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1021\/nn506248s","article-title":"Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles","volume":"9","author":"Cohen","year":"2015","journal-title":"ACS Nano"},{"issue":"30","key":"10.1016\/j.bioactmat.2023.11.007_bib328","doi-asserted-by":"crossref","first-page":"E6147","DOI":"10.1073\/pnas.1701911114","article-title":"Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression","volume":"114","author":"Yu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib329","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/10611860903046628","article-title":"Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic\u00aeP85, an in vitro cell line and in vivo biodistribution studies on rat model","volume":"17","author":"Shah","year":"2009","journal-title":"J. Drug Target."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib330","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1021\/nn402662d","article-title":"Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood\u2013brain tumor barrier","volume":"7","author":"Miura","year":"2013","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib331","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1054\/bjoc.2000.1459","article-title":"High intratumoural accumulation of stealth\u00ae liposomal doxorubicin (Caelyx\u00ae) in glioblastomas and in metastatic brain tumours","volume":"83","author":"Koukourakis","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib332","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.2147\/IJN.S117210","article-title":"Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier","volume":"11","author":"Vieira","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib333","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10611860500107401","article-title":"Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil","volume":"13","author":"Soni","year":"2005","journal-title":"J. Drug Target."},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib334","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1158\/1535-7163.MCT-06-0480","article-title":"Interleukin-13 receptor\u2013targeted nanovesicles are a potential therapy for glioblastoma multiforme","volume":"5","author":"Madhankumar","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib335","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijpharm.2010.07.039","article-title":"Reverse micelle-loaded lipid nano-emulsions: new technology for nano-encapsulation of hydrophilic materials","volume":"398","author":"Anton","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib336","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1166\/jbn.2015.2084","article-title":"Glioblastoma multiforme and lipid nanocapsules: a review","volume":"11","author":"Aparicio-Blanco","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib337","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/1535-7163.MCT-06-0289","article-title":"A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats","volume":"5","author":"Garcion","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib338","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.2147\/IJN.S165184","article-title":"Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma","volume":"13","author":"Ganipineni","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib339","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12951-019-0462-6","article-title":"Chlorotoxin peptide-functionalized polyethylenimine-entrapped gold nanoparticles for glioma SPECT\/CT imaging and radionuclide therapy","volume":"17","author":"Zhao","year":"2019","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib340","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1172\/JCI44798","article-title":"Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma","volume":"121","author":"Staquicini","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib341","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2057269","article-title":"Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model","volume":"14","author":"Zhao","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib342","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2018.03.006","article-title":"Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma","volume":"277","author":"Jhaveri","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib343","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.actbio.2018.10.012","article-title":"Transferrin\/aptamer conjugated mesoporous ruthenium nanosystem for redox-controlled and targeted chemo-photodynamic therapy of glioma","volume":"82","author":"Zhu","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib344","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jare.2023.01.005","article-title":"Antisense-oligonucleotide co-micelles with tumor targeting peptides elicit therapeutic effects by inhibiting microRNA-21 in the glioblastoma animal models","volume":"53","author":"Lee","year":"2023","journal-title":"J. Adv. Res."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib345","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10426","article-title":"Brain-targeted exosome-mimetic cell membrane nanovesicles with therapeutic oligonucleotides elicit anti-tumor effects in glioblastoma animal models","volume":"8","author":"Lee","year":"2023","journal-title":"Bioengineering & Translational Medicine"},{"issue":"20","key":"10.1016\/j.bioactmat.2023.11.007_bib346","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2217\/nnm-2018-0110","article-title":"Aurora kinase B siRNA-loaded lactoferrin nanoparticles potentiate the efficacy of temozolomide in treating glioblastoma","volume":"13","author":"Kumari","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib347","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2023.03.040","article-title":"Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma","volume":"357","author":"Janjua","year":"2023","journal-title":"J. Contr. Release"},{"issue":"15","key":"10.1016\/j.bioactmat.2023.11.007_bib348","doi-asserted-by":"crossref","first-page":"14191","DOI":"10.1021\/acsanm.3c02122","article-title":"Transferrin-conjugated PLGA nanoparticles for Co-delivery of temozolomide and bortezomib to glioblastoma cells","volume":"6","author":"Ramalho","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib349","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12951-021-01180-0","article-title":"Combined integrin \u03b1v\u03b23 and lactoferrin receptor targeted docetaxel liposomes enhance the brain targeting effect and anti-glioma effect","volume":"19","author":"Qi","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib350","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jgm.255","article-title":"Receptor-mediated delivery of an antisense gene to human brain cancer cells","volume":"4","author":"Zhang","year":"2002","journal-title":"J. Gene Med."},{"issue":"11","key":"10.1016\/j.bioactmat.2023.11.007_bib351","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1158\/1078-0432.CCR-03-0740","article-title":"Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer","volume":"10","author":"Zhang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib352","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.omto.2022.02.012","article-title":"A novel TanCAR targeting IL13R\u03b12 and EphA2 for enhanced glioblastoma therapy","volume":"24","author":"Muhammad","year":"2022","journal-title":"Mol Ther Oncolytics"},{"issue":"17","key":"10.1016\/j.bioactmat.2023.11.007_bib353","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-07-1493","article-title":"Expression of interleukin-13 receptor \u03b12 in glioblastoma multiforme: implications for targeted therapies","volume":"67","author":"Jarboe","year":"2007","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib354","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1158\/1535-7163.MCT-06-0480","article-title":"Interleukin-13 receptor\u2013targeted nanovesicles are a potential therapy for glioblastoma multiforme","volume":"5","author":"Madhankumar","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"issue":"18","key":"10.1016\/j.bioactmat.2023.11.007_bib355","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202207248","article-title":"Polyhedral oligomeric silsesquioxane-based nanoparticles for efficient chemotherapy of glioblastoma","volume":"19","author":"Zhong","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib356","first-page":"1","article-title":"Effect of folic acid-linked chitosan-coated PLGA-based curcumin nanoparticles on the redox system of glioblastoma cancer cells","author":"Ghoreyshi","year":"2023","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib357","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213442","article-title":"Targeted delivery of temozolomide by nanocarriers based on folic acid-hollow TiO2 -nanospheres for the treatment of glioblastoma","volume":"151","author":"Uribe-Robles","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib358","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2019.01.010","article-title":"Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma","volume":"108","author":"Emamgholizadeh Minaei","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib359","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1066887","article-title":"PEGylation and folic-acid functionalization of cationic lipoplexes\u2014improved nucleic acid transfer into cancer cells","volume":"10","author":"Hoffmann","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib360","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12951-021-00925-1","article-title":"Integrin \u03b12\u03b21-targeting ferritin nanocarrier traverses the blood\u2013brain barrier for effective glioma chemotherapy","volume":"19","author":"Huang","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib361","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.biomaterials.2012.12.049","article-title":"Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel","volume":"34","author":"Jiang","year":"2013","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib362","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1021\/acsnano.8b08177","article-title":"Radiation-induced targeted nanoparticle-based gene delivery for brain tumor therapy","volume":"13","author":"Erel-Akbaba","year":"2019","journal-title":"ACS Nano"},{"issue":"30","key":"10.1016\/j.bioactmat.2023.11.007_bib363","doi-asserted-by":"crossref","first-page":"21478","DOI":"10.18632\/oncotarget.25135","article-title":"Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model","volume":"9","author":"Malhotra","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib364","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2018.03.028","article-title":"RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy","volume":"543","author":"Hua","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib365","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtnano.2023.100347","article-title":"Targeted glioblastoma therapy by integrating brain-targeting peptides and corn-derived cancer cell-penetrating proteins into nanoparticles to cross blood-brain tumor barriers","volume":"23","author":"Zhang","year":"2023","journal-title":"Materials Today Nano"},{"issue":"15","key":"10.1016\/j.bioactmat.2023.11.007_bib366","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1039\/C9NJ05366B","article-title":"Paclitaxel-loaded dextran nanoparticles decorated with RVG29 peptide for targeted chemotherapy of glioma: an in vivo study","volume":"44","author":"Han","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib367","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121709","article-title":"Brain-targeting biomimetic nanoparticles for codelivery of celastrol and LY2157299 for reversing glioma immunosuppression","volume":"619","author":"Zhu","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"17","key":"10.1016\/j.bioactmat.2023.11.007_bib368","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105451","article-title":"Synchronous disintegration of ferroptosis defense Axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib369","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejpb.2018.09.012","article-title":"Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy","volume":"132","author":"Kadari","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib370","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12951-020-00751-x","article-title":"LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo","volume":"19","author":"He","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib371","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2018.04.035","article-title":"A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery","volume":"279","author":"Ruan","year":"2018","journal-title":"J. Contr. Release"},{"issue":"30","key":"10.1016\/j.bioactmat.2023.11.007_bib372","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201800316","article-title":"Protein toxin chaperoned by LRP-1-targeted virus-mimicking vesicles induces high-efficiency glioblastoma therapy in vivo","volume":"30","author":"Jiang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib373","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejpb.2016.08.013","article-title":"Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: in vitro evaluation on 2D and 3D tumor models","volume":"108","author":"Sarisozen","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib374","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jconrel.2020.12.036","article-title":"Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy","volume":"330","author":"Zhu","year":"2021","journal-title":"J. Contr. Release"},{"issue":"21","key":"10.1016\/j.bioactmat.2023.11.007_bib375","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1016\/j.biomaterials.2013.03.036","article-title":"The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells","volume":"34","author":"Gu","year":"2013","journal-title":"Biomaterials"},{"issue":"39","key":"10.1016\/j.bioactmat.2023.11.007_bib376","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1039\/C9TB01131E","article-title":"Chlorotoxin modified morusin\u2013PLGA nanoparticles for targeted glioblastoma therapy","volume":"7","author":"Agarwal","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib377","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1517\/14712598.2010.481667","article-title":"RNA interference therapy for glioblastoma","volume":"10","author":"Guo","year":"2010","journal-title":"Expet Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib378","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1789.2004.00600.x","article-title":"Genetic pathways to glioblastomas","volume":"25","author":"Ohgaki","year":"2005","journal-title":"Neuropathology"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib379","first-page":"677","article-title":"A Multivariate analysis of patients with brain tumors treated with ATN-RNA","volume":"65","author":"Wyszko","year":"2008","journal-title":"Acta Pol. Pharm."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib380","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4161\/cbt.5.8.2886","article-title":"Suppression of human brain tumor with interference RNA specific for tenascin-C","volume":"5","author":"Zukiel","year":"2006","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib381","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40824-019-0156-z","article-title":"Recent advances in the development of gene delivery systems","volume":"23","author":"Sung","year":"2019","journal-title":"Biomater. Res."},{"issue":"4025","key":"10.1016\/j.bioactmat.2023.11.007_bib382","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.175.4025.949","article-title":"Gene therapy for human genetic disease?","volume":"175","author":"Friedmann","year":"1972","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib383","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib384","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib385","first-page":"3391","article-title":"Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3","volume":"8","author":"Luan","year":"2015","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib386","first-page":"GE01","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res. : J. Clin. Diagn. Res."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib387","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib388","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fonc.2017.00195","article-title":"Oncolytic viruses\u2014interaction of virus and tumor cells in the battle to eliminate cancer","volume":"7","author":"Howells","year":"2017","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib389","first-page":"608","article-title":"Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene","volume":"3","author":"Ezzeddine","year":"1991","journal-title":"N. Biol."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib390","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/gt.2011.37","article-title":"Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12R\u03b22 or IL-18R\u03b1","volume":"18","author":"Choi","year":"2011","journal-title":"Gene Ther."},{"issue":"44","key":"10.1016\/j.bioactmat.2023.11.007_bib391","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.20800","article-title":"Adenovirus-mediated decorin expression induces cancer cell death through activation of p53 and mitochondrial apoptosis","volume":"8","author":"Yoon","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib392","first-page":"GE01","article-title":"Non viral vectors in gene therapy-an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res.: J. Clin. Diagn. Res."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib393","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s11095-010-0364-7","article-title":"Barriers to non-viral vector-mediated gene delivery in the nervous system","volume":"28","author":"P\u00e9rez-Mart\u00ednez","year":"2011","journal-title":"Pharmaceut. Res."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib394","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-021-00608-7","article-title":"Non-viral vectors in gene therapy: recent development, challenges, and prospects","volume":"23","author":"Zu","year":"2021","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib395","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.7150\/thno.38147","article-title":"Nanocarrier-based drug combination therapy for glioblastoma","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib396","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/nano9010105","article-title":"Vectors for glioblastoma gene therapy: viral & non-viral delivery strategies","volume":"9","author":"Caffery","year":"2019","journal-title":"Nanomaterials"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib397","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/pharmaceutics10040181","article-title":"Targeted theranostic nanoparticles for brain tumor treatment","volume":"10","author":"Mendes","year":"2018","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib398","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1021\/am5092165","article-title":"Temozolomide nanoparticles for targeted glioblastoma therapy","volume":"7","author":"Fang","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib399","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081115","article-title":"Targeted liposomes encapsulating miR-603 complexes enhance radiation sensitivity of patient-derived glioblastoma stem-like cells","volume":"13","author":"Shabana","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib400","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2016.08.029","article-title":"Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy","volume":"239","author":"Shatsberg","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib401","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.2147\/IJN.S139004","article-title":"Cytotoxicity induced by carbon nanotubes in experimental malignant glioma","volume":"12","author":"Romano-Feinholz","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib402","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.msec.2017.03.309","article-title":"Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery","volume":"77","author":"Song","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"issue":"584","key":"10.1016\/j.bioactmat.2023.11.007_bib403","doi-asserted-by":"crossref","first-page":"eabb3945","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference\u2013based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib404","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","volume":"11","author":"Gregory","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib405","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1038\/mtna.2013.60","article-title":"Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity","volume":"2","author":"Munoz","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib406","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjugate Chem."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib407","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","article-title":"Microenvironmental regulation of therapeutic response in cancer","volume":"25","author":"Klemm","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib408","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.actbio.2021.10.042","article-title":"Core-shell lipoplexes inducing active macropinocytosis promote intranasal delivery of c-Myc siRNA for treatment of glioblastoma","volume":"138","author":"Hu","year":"2022","journal-title":"Acta Biomater."},{"issue":"14","key":"10.1016\/j.bioactmat.2023.11.007_bib409","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2174\/0929867033457485","article-title":"The problem with cationic liposome\/micelle-based non-viral vector systems for gene therapy","volume":"10","author":"Miller","year":"2003","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib410","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0169-409X(01)00212-5","article-title":"A novel non-viral gene transfer system, polycation liposomes","volume":"52","author":"Oku","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib411","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202000054","article-title":"Lipid-based nanocarriers for the treatment of glioblastoma","volume":"1","author":"Iturrioz-Rodr\u00edguez","year":"2021","journal-title":"Advanced NanoBiomed Research"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib412","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41598-018-20632-6","article-title":"Oral delivery of siRNA lipid nanoparticles: fate in the GI tract","volume":"8","author":"Ball","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib413","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbrc.2014.02.120","article-title":"Delivery of kinesin spindle protein targeting siRNA in solid lipid nanoparticles to cellular models of tumor vasculature","volume":"446","author":"Ying","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"49","key":"10.1016\/j.bioactmat.2023.11.007_bib414","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-Acetylgalactosamine-Conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib415","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0006-291X(02)02485-3","article-title":"Visualization of intracellular trafficking of exogenous DNA delivered by cationic liposomes","volume":"298","author":"Kamiya","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib416","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib417","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijpharm.2011.01.048","article-title":"Cationic nanoemulsion as a delivery system for oligonucleotides targeting malarial topoisomerase II","volume":"416","author":"Bruxel","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib418","first-page":"3141","article-title":"Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin","volume":"8","author":"Jiang","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"Pt A","key":"10.1016\/j.bioactmat.2023.11.007_bib419","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib420","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1166\/jbn.2014.1804","article-title":"Inclusion of the helper lipid dioleoyl-phosphatidylethanolamine in solid lipid nanoparticles inhibits their transfection efficiency","volume":"10","author":"de Jesus","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib421","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/pharmaceutics12060584","article-title":"Topical administration of SLN-based gene therapy for the treatment of corneal inflammation by de novo IL-10 production","volume":"12","author":"Vicente-Pascual","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib422","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijpharm.2011.12.052","article-title":"Dextran\u2013protamine\u2013solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice","volume":"425","author":"Delgado","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib423","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.drudis.2016.10.014","article-title":"miRNA nanotherapeutics for cancer","volume":"22","author":"Ganju","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib424","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/pharmaceutics13081115","article-title":"Targeted liposomes encapsulating miR-603 complexes enhance radiation sensitivity of patient-derived glioblastoma stem-like cells","volume":"13","author":"Shabana","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib425","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jconrel.2020.08.028","article-title":"Intracellular trafficking and functional monitoring of miRNA delivery in glioblastoma using lipopolyplexes and the miRNA-ON RILES reporter system","volume":"327","author":"Simion","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib426","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2147\/IJN.S241055","article-title":"Brain targeted gold liposomes improve RNAi delivery for glioblastoma","volume":"15","author":"Grafals-Ruiz","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib427","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00018-019-03317-9","article-title":"Nanoscale delivery systems for microRNAs in cancer therapy","volume":"77","author":"Boca","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib428","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12951-016-0239-0","article-title":"Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging","volume":"14","author":"Asem","year":"2016","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib429","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105373","article-title":"Structure-based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles","volume":"9","author":"De","year":"2022","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib430","doi-asserted-by":"crossref","first-page":"14197","DOI":"10.1021\/acsanm.1c03664","article-title":"Piperine-loaded PLGA nanoparticles as cancer drug carriers","volume":"4","author":"Kaur","year":"2021","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib431","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jconrel.2022.07.023","article-title":"Polymeric nanoparticles for drug delivery in glioblastoma: state of the art and future perspectives","volume":"349","author":"Madani","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib432","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2016.08.029","article-title":"Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy","volume":"239","author":"Shatsberg","year":"2016","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib433","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3892\/or.2013.2283","article-title":"Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells","volume":"29","author":"Liu","year":"2013","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.bioactmat.2023.11.007_bib434","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1021\/acs.molpharmaceut.5b00694","article-title":"Nanoparticle-delivered antisense MicroRNA-21 enhances the effects of temozolomide on glioblastoma cells","volume":"12","author":"Ananta","year":"2015","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.11.007_bib435","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.biomaterials.2013.11.039","article-title":"Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma","volume":"35","author":"Qian","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib436","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1163\/156856209X415828","article-title":"Co-Delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro","volume":"21","author":"Ren","year":"2010","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"21","key":"10.1016\/j.bioactmat.2023.11.007_bib437","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.2182","article-title":"Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid","volume":"5","author":"Porru","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib438","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/1061186X.2020.1841214","article-title":"Dual functional nanoparticles efficiently across the blood\u2013brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis","volume":"29","author":"Jin","year":"2021","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib439","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/IJN.S198353","article-title":"Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib440","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/1061186X.2017.1367006","article-title":"General overview of lipid\u2013polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes","volume":"26","author":"Wakaskar","year":"2018","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib441","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1166\/jbn.2015.1965","article-title":"Arginine-glycine-aspartic acid-modified lipid-polymer hybrid nanoparticles for docetaxel delivery in glioblastoma multiforme","volume":"11","author":"Shi","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib442","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/molecules22050782","article-title":"Mesoporous silica nanoparticles as carriers for intracellular delivery of nucleic acids and subsequent therapeutic applications","volume":"22","author":"Cha","year":"2017","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bioactmat.2023.11.007_bib443","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1039\/C3DT52522H","article-title":"Calcium phosphate nanoparticles: a study of their synthesis, characterization and mode of interaction with salmon testis DNA","volume":"43","author":"Banik","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib444","volume":"vol. 2013","author":"Mulens","year":"2013"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib445","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/mp3005885","article-title":"Multifunctional gold nanoparticles for diagnosis and therapy of disease","volume":"10","author":"Mieszawska","year":"2013","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib446","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/smll.200400093","article-title":"Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity","volume":"1","author":"Connor","year":"2005","journal-title":"Small"},{"issue":"14","key":"10.1016\/j.bioactmat.2023.11.007_bib447","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1021\/jp057170o","article-title":"Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine","volume":"110","author":"Jain","year":"2006","journal-title":"J. Phys. Chem. B"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib448","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1039\/C0CS00018C","article-title":"Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies","volume":"40","author":"Khlebtsov","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"20","key":"10.1016\/j.bioactmat.2023.11.007_bib449","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1002\/smll.201400963","article-title":"Combined magnetic nanoparticle-based MicroRNA and hyperthermia therapy to enhance apoptosis in brain cancer cells","volume":"10","author":"Yin","year":"2014","journal-title":"Small"},{"issue":"24","key":"10.1016\/j.bioactmat.2023.11.007_bib450","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1016\/j.biomaterials.2014.04.057","article-title":"Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging","volume":"35","author":"Yang","year":"2014","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib451","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3892\/ijo.2016.3571","article-title":"Magnetofection based on superparamagnetic iron oxide nanoparticle-mediated low lncRNA HOTAIR expression decreases the proliferation and invasion of glioma stem cells","volume":"49","author":"Fang","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib452","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/0008-5472.CAN-18-2170","article-title":"Temozolomide treatment induces lncRNA MALAT1 in an NF-\u03baB and p53 codependent manner in glioblastoma","volume":"79","author":"Voce","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib453","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119342","article-title":"Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide","volume":"218","author":"Sukumar","year":"2019","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib454","article-title":"Porous metal-organic frameworks for gas storage and separation: status and challenges","volume":"1","author":"Li","year":"2019","journal-title":"Inside Energy"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib455","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1021\/acsami.1c01089","article-title":"Metal\u2013organic frameworks for drug delivery: a design perspective","volume":"13","author":"Lawson","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib456","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1039\/D0RA09878G","article-title":"Recent advances in nanosized metal organic frameworks for drug delivery and tumor therapy","volume":"11","author":"Yang","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib457","first-page":"145","article-title":"Magnetic covalent organic framework nanospheres-based miRNA biosensor for sensitive glioma detection","volume":"14","author":"Liang","year":"2022","journal-title":"Bioact. Mater."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib458","doi-asserted-by":"crossref","first-page":"nwac006","DOI":"10.1093\/nsr\/nwac006","article-title":"Construction of nanocarriers based on nucleic acids and their applications in nanobiology delivery systems","volume":"9","author":"Guo","year":"2022","journal-title":"Natl. Sci. Rev."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib459","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41578-021-00315-x","article-title":"Multifunctional biomolecule nanostructures for cancer therapy","volume":"6","author":"Wang","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.11.007_bib460","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1021\/jacs.8b10795","article-title":"Engineering of bioinspired, size-controllable, self-degradable cancer-targeting DNA nanoflowers via the incorporation of an artificial sandwich base","volume":"141","author":"Zhang","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"18","key":"10.1016\/j.bioactmat.2023.11.007_bib461","doi-asserted-by":"crossref","first-page":"15504","DOI":"10.1021\/acsami.8b03464","article-title":"Isothermal self-assembly of spermidine\u2013DNA nanostructure complex as a functional platform for cancer therapy","volume":"10","author":"Wang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"28","key":"10.1016\/j.bioactmat.2023.11.007_bib462","doi-asserted-by":"crossref","first-page":"23693","DOI":"10.1021\/acsami.8b07889","article-title":"Self-assembled double-bundle DNA tetrahedron for efficient antisense delivery","volume":"10","author":"Yang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"44","key":"10.1016\/j.bioactmat.2023.11.007_bib463","doi-asserted-by":"crossref","first-page":"41082","DOI":"10.1021\/acsami.9b14892","article-title":"pH-responsive and gemcitabine-containing DNA nanogel to facilitate the chemodrug delivery","volume":"11","author":"Pan","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib464","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.mattod.2016.09.012","article-title":"Nucleic acid-templated functional nanocomposites for biomedical applications","volume":"20","author":"Zhou","year":"2017","journal-title":"Mater. Today"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib465","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1021\/acs.analchem.6b03346","article-title":"Diagnosis\u2013therapy integrative systems based on magnetic RNA nanoflowers for Co-drug delivery and targeted therapy","volume":"89","author":"Guo","year":"2017","journal-title":"Anal. Chem."},{"issue":"42","key":"10.1016\/j.bioactmat.2023.11.007_bib466","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1021\/ja5079464","article-title":"Synthetic aptamer-polymer hybrid constructs for programmed drug delivery into specific target cells","volume":"136","author":"Oh","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.11.007_bib467","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1158\/0008-5472.CAN-15-2073","article-title":"Delivery of therapeutics targeting the mRNA-binding protein HuR using 3DNA nanocarriers suppresses ovarian tumor growth","volume":"76","author":"Huang","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib468","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/s41467-017-01386-7","article-title":"Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib469","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2020.03.040","article-title":"Nucleic acid-based drug delivery strategies","volume":"323","author":"Tan","year":"2020","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib470","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1039\/C7SC01619K","article-title":"Precision spherical nucleic acids for delivery of anticancer drugs","volume":"8","author":"Bousmail","year":"2017","journal-title":"Chem. Sci."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib471","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12274-019-2271-5","article-title":"Efficient renal clearance of DNA tetrahedron nanoparticles enables quantitative evaluation of kidney function","volume":"12","author":"Jiang","year":"2019","journal-title":"Nano Res."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.11.007_bib472","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/acsnano.6b05737","article-title":"Advancement of the emerging field of RNA nanotechnology","volume":"11","author":"Jasinski","year":"2017","journal-title":"ACS Nano"},{"issue":"209","key":"10.1016\/j.bioactmat.2023.11.007_bib473","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006839","article-title":"Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma","volume":"5","author":"Jensen","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.11.007_bib474","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202006116","article-title":"A virus-mimicking nucleic acid nanogel reprograms microglia and macrophages for glioblastoma therapy","volume":"33","author":"Gao","year":"2021","journal-title":"Adv. Mater."},{"issue":"47","key":"10.1016\/j.bioactmat.2023.11.007_bib475","doi-asserted-by":"crossref","first-page":"14286","DOI":"10.1021\/acs.langmuir.8b02616","article-title":"Effect of the aspect ratio of coiled-coil protein carriers on cellular uptake","volume":"34","author":"Nakayama","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.bioactmat.2023.11.007_bib476","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.addr.2016.03.002","article-title":"Bioengineered protein-based nanocage for drug delivery","volume":"106","author":"Lee","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib477","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2020.101395","article-title":"Protein nanocage architectures for the delivery of therapeutic proteins","volume":"51","author":"Wang","year":"2021","journal-title":"Curr. Opin. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.11.007_bib478","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41427-022-00453-w","article-title":"Protein nanoparticle cellular fate and responses in murine macrophages","volume":"15","author":"Ravishankar","year":"2023","journal-title":"NPG Asia Mater."},{"issue":"29","key":"10.1016\/j.bioactmat.2023.11.007_bib479","article-title":"Bioengineered dual-targeting protein nanocage for stereoscopical loading of synergistic hydrophilic\/hydrophobic drugs to enhance anticancer efficacy","volume":"31","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib480","doi-asserted-by":"crossref","DOI":"10.1038\/am.2016.128","article-title":"Engineering protein nanocages as carriers for biomedical applications","volume":"9","author":"Bhaskar","year":"2017","journal-title":"NPG Asia Mater."},{"issue":"41","key":"10.1016\/j.bioactmat.2023.11.007_bib481","doi-asserted-by":"crossref","first-page":"14900","DOI":"10.1073\/pnas.1407808111","article-title":"H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection","volume":"111","author":"Liang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.11.007_bib482","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1021\/acsbiomaterials.3c00189","article-title":"Transglutaminase-polyethyleneimine nanoflowers mediated cellular delivery of anti-miR-210 for effective glioblastoma therapy","volume":"9","author":"Mondal","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bioactmat.2023.11.007_bib483","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2147\/IJN.S241055","article-title":"Brain targeted gold liposomes improve RNAi delivery for glioblastoma","volume":"15","author":"Grafals-Ruiz","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.11.007_bib484","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3892\/or.2013.2283","article-title":"Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells","volume":"29","author":"Liu","year":"2013","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.11.007_bib485","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/1061186X.2020.1841214","article-title":"Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis","volume":"29","author":"Jin","year":"2021","journal-title":"J. Drug Target."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X23003560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X23003560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:49:25Z","timestamp":1762786165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X23003560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":485,"alternative-id":["S2452199X23003560"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2023.11.007","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered smart materials for RNA based molecular therapy to treat Glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2023.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}